pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
etentamig
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
0
catalysts
Marketed
ethacrynate sodium
Ethacrynate Sodium (ethacrynate sodium)
Hepatic Edema
SteriMax Inc
0
catalysts
Marketed
ethacrynic acid
Ethacrynic Acid (ethacrynic acid)
Lymphedema
Agnitio Inc
0
catalysts
Phase 2
← prev
page 46 of 62
next →
131
Pain
89
Neurology
1
etigilimab
Adenocarcinoma Of The Gastroesophageal Junction
T-cell immunoreceptor with Ig and ITIM domains
$MREO
Mereo BioPharma Group plc
0
catalysts
Phase 2
etivelcabtagene erigedleucel
Follicular Lymphoma
Cellectis SA
0
catalysts
Phase 2
evalstotug
evalstotug [INN]
Melanoma
$BCAB
BioAtla, Inc.
0
catalysts
Phase 2
evarucabgene autoleucel
Refractory Multiple Myeloma
Nexcella Inc
0
catalysts
Phase 3
evorpacept
Adenocarcinoma Of The Gastroesophageal Junction
Leukocyte surface antigen CD47
$ALXO
ALX ONCOLOGY HOLDINGS INC
0
catalysts
Phase 1
exarafenib
exarafenib [INN]
Melanoma
Laboratoires Pierre Fabre SA
0
catalysts
Phase 2
ezurpimtrostat
ezurpimtrostat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Genfit SA
0
catalysts
Phase 1
faldoritinib
Refractory Acute Myeloid Leukemia
$BMEA
Biomea Fusion, Inc.
0
catalysts
Marketed
famotidine
Pepcid (famotidine)
Acid Indigestion (Heartburn/Pyrosis)
$KVUE
Kenvue Inc.
0
catalysts
Phase 1
faridoxorubicin
faridoxorubicin [INN]
Dedifferentiated Liposarcoma
Avacta Life Sciences Ltd
0
catalysts
Phase 2
farletuzumab ecteribulin
Triple-Negative Breast Cancer (TNBC)
Eisai Co Ltd
0
catalysts
Phase 1
fb-PMT
Recurrent Glioblastoma Multiforme (GBM)
NanoPharmaceuticals LLC
0
catalysts
Phase 2
fenretinide
Dengue Fever
$ILPLF
Island Pharmaceuticals Ltd
0
catalysts
Phase 2
fexapotide triflutate
Prostate Cancer
$NYMXF
NYMOX PHARMACEUTICAL CORP
0
catalysts
Phase 3
fianlimab
Metastatic Melanoma
Lymphocyte activation gene 3 protein
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
ficerafusp alfa
Recurrent Head And Neck Squamous Cell Carcinoma
$BCAX
Bicara Therapeutics Inc.
0
catalysts
Phase 3
ficlatuzumab
Recurrent Head And Neck Squamous Cell Carcinoma
Hepatocyte growth factor
AVEO Pharmaceuticals Inc
0
catalysts
Marketed
fingolimod ODT
Tascenso ODT (fingolimod [INN])
Multiple Sclerosis
Cycle Pharmaceuticals Ltd
0
catalysts
Phase 1
flezurafenib
Hematological Tumor
$JAZZ
Jazz Pharmaceuticals plc
0
catalysts
Phase 2
flixebrutinib
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Telios Pharma Inc
0
catalysts
Marketed
floxuridine
Floxuridine (floxuridine)
Adenocarcinoma Of The Gastroesophageal Junction
Fresenius Kabi USA LLC
0
catalysts
Phase 2
flucytosine ER + vocimagene amiretrorepvec
flucytosine + vocimagene amiretrorepvec
Glioblastoma Multiforme (GBM)
Denovo Biopharma LLC
0
catalysts
Marketed
fludarabine phosphate
Fludarabine Phosphate (fludarabine phosphate)
B-Cell Chronic Lymphocytic Leukemia
Areva Pharmaceuticals Inc
0
catalysts
Marketed
flutamide
Flutamide (flutamide)
Metastatic Prostate Cancer
Par Pharmaceutical Inc
0
catalysts
Preclinical
fosbretabulin tromethamine
Metastatic Melanoma
$OTLC
Oncotelic Therapeutics, Inc.
0
catalysts
Phase 2
foscenvivint
foscenvivint [INN]
Colorectal Cancer
Eisai Co Ltd
0
catalysts
Phase 2
fosdesdenosine sipalabenamide
fosdesdenosine sipalabenamide [INN]
Metastatic Melanoma
$NCNA
NuCana plc
0
catalysts
